Neuraminidase-IN-2
Neuraminidase-IN-2 is an anti-influenza compounds with IC50 values of 0.28, 0.27, 11.50, 0.089 and 23.44 µM for H1N1, 09H1N1, H3N2, H5N1 and H5N2, respectively. Neuraminidase-IN-2 has antiviral activity and low cytotoxicity[1].
Product Specifications
CAS Number
2599015-44-6
UNSPSC
12352005
Target
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/neuraminidase-in-2.html
Solubility
10 mM in DMSO
Smiles
COC1=CC(COC2=CC=C(CN[C@@H]3[C@@H](NC(C)=O)[C@H](OC(CC)CC)C=C(C(O)=O)C3)C=C2)=CC=C1
Molecular Formula
C29H38N2O6
Molecular Weight
510.62
References & Citations
[1] Jia R, et al. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity. Eur J Med Chem. 2021 Feb 15;212:113097.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-E917380-50MG 50 mg
4-Ethyl-N,N-diphenyl-1-naphthalenecarboxamide
Sign In for Pricing
View Details 
PKSV030384-01 50 µg
Recombinant SARS-CoV-2 Spike RBD-SD1 (N354D, D364Y, ) (His Tag)
Sign In for Pricing
View Details PKSV030384-02 500 µg
Recombinant SARS-CoV-2 Spike RBD-SD1 (N354D, D364Y, ) (His Tag)
Sign In for Pricing
View Details 
BNC741067-500 1x 500 µL
HLA-DRB (HLA-DRB/1067), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details